NCT01799902View on ClinicalTrials.gov

Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms (Overactive Bladder Syndrome)

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Lower Urinary Tract Predominant Storage Symptoms
Interventions
DRUG

Solifenacin

Oral

Trial Locations (15)

1070

Erasme, Brussels

1090

UZ Brussel, Brussels

1180

Private practice, Brussels

2060

ZNA Stuyvenberg, Antwerp

2100

AZ St. Monica, Deurne

2650

UZ Antwerpen, Edegem

8400

AZ Damiaan, Ostend

8500

AZ Groeninge, Kortrijk

8800

H.Hart Roeselaere, Roeselaere

9000

Maria Middelares, Ghent

Sint-Lucas, Ghent

UZ Gent, Ghent

9300

ASZ, Aalst

9620

AZ Sint Elisabeth, Zottegem

9700

AZ Oudenaarde, Oudenaarde

Sponsors

Collaborators (1)

Veeda Clinical Research
All Listed Sponsors
collaborator

Veeda Clinical Research

INDUSTRY

lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT01799902 - Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms (Overactive Bladder Syndrome) | Biotech Hunter | Biotech Hunter